Citadel Advisors’s JLens 500 Jewish Advocacy U.S. ETF TOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$241K Buy
+8,823
New +$252K ﹤0.01% 10987
2025
Q4
Sell
-14,663
Closed -$412K 14564
2025
Q3
$412K Buy
+14,663
New +$396K ﹤0.01% 9596

Other funds holding TOV

Citadel Advisors's TOV Position: Q1 2026 in Review

Citadel Advisors opened a new position in JLens 500 Jewish Advocacy U.S. ETF (TOV) in Q1 2026: 8,823 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #10987 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in TOV as recently as Q3 2025.

Citadel Advisors first reported a position in TOV in Q3 2025 and has held it in 2 quarters since. The position peaked at $412K in Q3 2025. 22 funds tracked by Wall St. Rank hold TOV as of Q1 2026.

  • Citadel Advisors held 8,823 shares of JLens 500 Jewish Advocacy U.S. ETF worth $241K as of Q1 2026.
  • JLens 500 Jewish Advocacy U.S. ETF was a new Citadel Advisors position in Q1 2026.
  • JLens 500 Jewish Advocacy U.S. ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10987 holding.
  • Citadel Advisors first reported a position in JLens 500 Jewish Advocacy U.S. ETF in Q3 2025 and has held it in 2 quarters since.
  • Citadel Advisors's JLens 500 Jewish Advocacy U.S. ETF position peaked at $412K in Q3 2025.
  • 22 funds tracked by Wall St. Rank held JLens 500 Jewish Advocacy U.S. ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.